Home
Conditions
Ovarian Neoplasms

Clinical trial condition

Ovarian Neoplasms

Explore clinical trials studying Ovarian Neoplasms. Study availability and eligibility vary by location and protocol.

2,296 public trials 506 recruiting studies

Refine in advanced search Browse all conditions

Ovarian Neoplasms trial results

Completed

A Trial of Atezolizumab and Vigil in Patients With Advanced Gynecological Cancers

NCT03073525

Conditions: Adnexal Diseases, Advanced Gynecological Cancers, Cervical Cancer, +20 more
Locations: University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States

Georgia Cancer Center at Augusta University Augusta, Georgia, United States

Henry Ford Hospital Detroit, Michigan, United States

Billings Clinic Billings, Montana, United States

View Trial Details

Completed

FT516 and IL2 With Enoblituzumab for Ovarian Cancer

NCT04630769

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +15 more
Locations: University of Minnesota, Masonic Cancer Center Minneapolis, Minnesota, United States

View Trial Details

Completed

A Study of JNJ-78306358 in Participants With Advanced Stage Solid Tumors

NCT04991740

Conditions: Adnexal Diseases, Colonic Diseases, Colorectal Neoplasms, +26 more
Locations: Rambam Medical Center Haifa, Israel

Sourasky Medical Center Tel Aviv, Israel

Hosp. Univ. Vall D Hebron Barcelona, Spain

Hosp. Univ. Fund. Jimenez Diaz Madrid, Spain

View Trial Details

Completed

PARP Inhibition During Pre-surgical Window in Breast/Ovary Cancer

NCT04041128

Conditions: Adnexal Diseases, Breast Cancer, Breast Diseases, +18 more
Locations: University of Texas Southwestern Medical Center Dallas, Texas, United States

View Trial Details

Completed

Anti-programmed Cell Death-1 Ligand 1 (aPDL-1) Antibody Atezolizumab, Bevacizumab and Acetylsalicylic Acid in Recurrent Platinum Resistant Ovarian Cancer

NCT02659384

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +12 more
Locations: Assistance Publique - Hopitaux de Paris - Hopital Europeen Georges Pompidou Paris, France

Centre Hospitalier Privé Saint-Grégoire Saint-Grégoire, France

Academisch Medisch Centrum - Universiteit van Amsterdam Amsterdam, Netherlands

Leiden University Medical Centre Leiden, Netherlands

View Trial Details

Completed

Evaluating the Performance of Morphology Index in Surgical Decision-Making for Ovarian Tumors

NCT02227654

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +12 more
Locations: Markey Cancer Center, University of Kentucky Lexington, Kentucky, United States

View Trial Details

Completed

TIL Therapy in Combination With Checkpoint Inhibitors for Metastatic Ovarian Cancer

NCT03287674

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations: Center for Cancer Immune Therapy Dept. of Hematology/oncology Copenhagen, Denmark

View Trial Details

Completed

Arginase-1 Peptide Vaccine in Patients With Metastatic Solid Tumors

NCT03689192

Conditions: Adnexal Diseases, Breast Cancer, Breast Diseases, +59 more
Locations: Center for Cancer Immune Therapy Dept. of Hematology/oncology Copenhagen, Herlev, Denmark

View Trial Details

Completed

TAK-659 and Paclitaxel in Treating Patients With Advanced Solid Tumors

NCT03756818

Conditions: Adnexal Diseases, Advanced Malignant Solid Neoplasm, Endocrine Gland Neoplasms, +16 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, and IDO1 Inhibitor INCB024360 in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission

NCT02166905

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Ovarian Neoplasms

Ovarian Neoplasms trial results

Related conditions